Abstract
A novel, dinuclear and dissolvable palladium(II) complex of [{Pd(en)Cl}2(μ-p-ph-da)](NO3)2, where en is ethylenediamine and p-ph-da is 1,4-phenylenediamine, was synthesized by the reaction between [Pd(en)(dmf)Cl](NO3) (dmf = dimethyl formamide) and p-ph-da in the molar ratio of 2:1. The structure and formulation of the complex were also proposed on the bases of elemental analysis, conductivity measurements, and spectral (FT-IR, UV–Vis, and NMR (1H and D2O exchange)) data. The complex was screened for its antitumor activity against MOLT-4 have shown a significant decrease in viability after 24 h which was also dose-dependent. Rich CT-DNA and BSA interaction studies including absorption, fluorescence, thermodynamic, energy transfer, electrophoresis, cyclic voltammetry, and circular dichroism revealed that hydrogen-binding, van der Waals, and electrostatic attractions are different binding forces for the complex interacting with the above biomacromolecules. Likewise, molecular docking simulation supports the above experimental conclusions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.